Janssens’ COVID-19 vaccine effective against SARS-CoV-2 Delta variant
Researchers in the Netherlands have conducted a study showing that Janssen’s Ad26.COV2.S coronavirus disease 2019 (COVID‐19) vaccine was effective against
Read more
cipro 750mg
The phase 1/2 trial of the REGEN-COV (casirivimab and imdevimab) antibody cocktail from Regeneron conducted on 799 individuals shows that
Read more
Long-range airborne transmission of SARS-CoV-2
Infectious droplets generated by coughing, sneezing, or just ordinary speech and breathing have generally been categorized based on size between
Read more
SARS-CoV-2 B.1.1.345 variant carrying E484K mutation detected in New York
As vaccine rollouts against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus behind the coronavirus disease (COVID-19) pandemic,
Read more
How SARS-CoV-2 variant B.1.1.7 adapted to evade innate immunity
Researchers in the United States and the UK have conducted a study showing how the B.1.1.7 (Alpha) lineage of severe
Read more
SARS-CoV-2 variant B.1.617 may be more transmissible and pathogenic due to spike cleavage
In a new research paper currently available on the bioRxiv* preprint server, a research group from the United Kingdom (UK)
Read more
Modeling SARS-CoV-2 spike/human ACE2 complex identifies high-affinity variants that cause greater transmissibility
The coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread across the
Read more
Scientists discover novel defensive response to SARS-CoV-2
Scientists from Hokkaido University have discovered a novel defensive response to SARS-CoV-2 that involves the viral pattern recognition receptor RIG-I.
Read more
Study identifies mechanism behind SARS-CoV-2 fusion of host cells
The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is mediated by the fusion of the spike protein to
Read more
6000mah lithium polymer battery
Researchers in the United States have provided the first evidence that messenger RNA (mRNA)-based vaccines against severe acute respiratory coronavirus
Read more